for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Gilead, Merck collaborate to develop HIV treatment - WSJ

March 15 (Reuters) - Drug makers Gilead Sciences Inc and Merck & Co Inc are collaborating to develop a long-acting HIV therapy, the Wall Street Journal reported on Monday. (Reporting By Mrinalika Roy in Bengaluru; Editing by Shounak Dasgupta)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up